Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Mol Psychiatry ; 29(5): 1241-1252, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38243074

RESUMEN

Abnormalities in functional brain networks (functional connectome) are increasingly implicated in people at Clinical High Risk for Psychosis (CHR-P). Intranasal oxytocin, a potential novel treatment for the CHR-P state, modulates network topology in healthy individuals. However, its connectomic effects in people at CHR-P remain unknown. Forty-seven men (30 CHR-P and 17 healthy controls) received acute challenges of both intranasal oxytocin 40 IU and placebo in two parallel randomised, double-blind, placebo-controlled cross-over studies which had similar but not identical designs. Multi-echo resting-state fMRI data was acquired at approximately 1 h post-dosing. Using a graph theoretical approach, the effects of group (CHR-P vs healthy control), treatment (oxytocin vs placebo) and respective interactions were tested on graph metrics describing the topology of the functional connectome. Group effects were observed in 12 regions (all pFDR < 0.05) most localised to the frontoparietal network. Treatment effects were found in 7 regions (all pFDR < 0.05) predominantly within the ventral attention network. Our major finding was that many effects of oxytocin on network topology differ across CHR-P and healthy individuals, with significant interaction effects observed in numerous subcortical regions strongly implicated in psychosis onset, such as the thalamus, pallidum and nucleus accumbens, and cortical regions which localised primarily to the default mode network (12 regions, all pFDR < 0.05). Collectively, our findings provide new insights on aberrant functional brain network organisation associated with psychosis risk and demonstrate, for the first time, that oxytocin modulates network topology in brain regions implicated in the pathophysiology of psychosis in a clinical status (CHR-P vs healthy control) specific manner.


Asunto(s)
Encéfalo , Conectoma , Imagen por Resonancia Magnética , Oxitocina , Trastornos Psicóticos , Humanos , Oxitocina/farmacología , Oxitocina/administración & dosificación , Masculino , Conectoma/métodos , Trastornos Psicóticos/tratamiento farmacológico , Trastornos Psicóticos/fisiopatología , Imagen por Resonancia Magnética/métodos , Método Doble Ciego , Adulto , Encéfalo/efectos de los fármacos , Encéfalo/fisiopatología , Adulto Joven , Estudios Cruzados , Administración Intranasal , Red Nerviosa/efectos de los fármacos , Red Nerviosa/fisiopatología , Red Nerviosa/diagnóstico por imagen , Adolescente , Riesgo
2.
Transl Psychiatry ; 10(1): 203, 2020 06 22.
Artículo en Inglés | MEDLINE | ID: mdl-32572020

RESUMEN

Social deficits are key hallmarks of the Clinical High Risk for Psychosis (CHR-P) state and of established psychotic disorders, and contribute to impaired social functioning, indicating a potential target for interventions. However, current treatments do not significantly ameliorate social impairments in CHR-P individuals. Given its critical role in social behaviour and cognition, the oxytocinergic (OT) system is a promising target for novel interventions in CHR-P subjects. In a double-blind, placebo-controlled, crossover design, 30 CHR-P males were studied using functional magnetic resonance imaging (fMRI) on two occasions, once after 40IU self-administered intranasal OT and once after placebo. A modified version of the Sally-Anne task was used to assess brain activation during inferring others' beliefs and social emotions. The Reading the Mind in the Eyes Test was acquired prior to the first scan to test whether OT effects were moderated by baseline social-emotional abilities. OT did not modulate behavioural performances but reduced activation in the bilateral inferior frontal gyrus compared with placebo while inferring others' social emotions. Furthermore, the relationship between brain activation and task performance after OT administration was moderated by baseline social-emotional abilities. While task accuracy during inferring others' social emotion increased with decreasing activation in the left inferior frontal gyrus in CHR-P individuals with low social-emotional abilities, there was no such relationship in CHR-P individuals with high social-emotional abilities. Our findings may suggest that acute OT administration enhances neural efficiency in the inferior frontal gyrus during inferring others' social emotions in those CHR-P subjects with low baseline social-emotional abilities.


Asunto(s)
Oxitocina , Trastornos Psicóticos , Administración Intranasal , Encéfalo/diagnóstico por imagen , Estudios Cruzados , Método Doble Ciego , Emociones , Humanos , Imagen por Resonancia Magnética , Masculino , Trastornos Psicóticos/tratamiento farmacológico
3.
Eur Neuropsychopharmacol ; 29(5): 601-615, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30928180

RESUMEN

Alterations in neurochemical metabolites are thought to play a role in the pathophysiology of psychosis onset. Oxytocin, a neuropeptide with prosocial and anxiolytic properties, modulates glutamate neurotransmission in preclinical models but its neurochemical effects in people at high risk for psychosis are unknown. We used proton magnetic resonance spectroscopy (1H-MRS) to examine the effects of intranasal oxytocin on glutamate and other metabolites in people at Clinical High Risk for Psychosis (CHR-P) in a double-blind, placebo-controlled, crossover design. 30 CHR-P males were studied on two occasions, once after 40IU intranasal oxytocin and once after placebo. The effects of oxytocin on the concentration of glutamate, glutamate+glutamine and other metabolites (choline, N-acetylaspartate, myo-inositol) scaled to creatine were examined in the left thalamus, anterior cingulate cortex (ACC) and left hippocampus, starting approximately 75, 84 and 93 min post-dosing, respectively. Relative to placebo, administration of oxytocin was associated with an increase in choline levels in the ACC (p=.008, Cohen's d = 0.54). There were no other significant effects on metabolite concentrations (all p>.05). Our findings suggest that, at ∼75-99 min post-dosing, a single dose of intranasal oxytocin does not alter levels of neurochemical metabolites in the thalamus, ACC, or hippocampus in those at CHR-P, aside from potential effects on choline in the ACC.


Asunto(s)
Química Encefálica/efectos de los fármacos , Química Encefálica/fisiología , Oxitocina/administración & dosificación , Trastornos Psicóticos/tratamiento farmacológico , Trastornos Psicóticos/metabolismo , Administración Intranasal , Adolescente , Adulto , Estudios Cruzados , Método Doble Ciego , Ácido Glutámico/metabolismo , Glutamina/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Humanos , Espectroscopía de Resonancia Magnética/métodos , Masculino , Trastornos Psicóticos/diagnóstico por imagen , Factores de Riesgo , Tálamo/efectos de los fármacos , Tálamo/metabolismo , Adulto Joven
4.
Neuropsychopharmacology ; 44(7): 1300-1309, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30626906

RESUMEN

Preclinical and human studies suggest that hippocampal dysfunction is a key factor in the onset of psychosis. People at Clinical High Risk for psychosis (CHR-P) present with a clinical syndrome that can include social withdrawal and have a 20-35% risk of developing psychosis in the next 2 years. Recent research shows that resting hippocampal blood flow is altered in CHR-P individuals and predicts adverse clinical outcomes, such as non-remission/transition to frank psychosis. Previous work in healthy males indicates that a single dose of intranasal oxytocin has positive effects on social function and marked effects on resting hippocampal blood flow. The present study examined the effects of intranasal oxytocin on hippocampal blood flow in CHR-P individuals. In a double-blind, placebo-controlled, crossover design, 30 CHR-P males were studied using pseudo-continuous Arterial Spin Labelling on 2 occasions, once after 40IU intranasal oxytocin and once after placebo. The effects of oxytocin on left hippocampal blood flow were examined in a region-of-interest analysis of data acquired at 22-28 and at 30-36 minutes post-intranasal administration. Relative to placebo, administration of oxytocin was associated with increased hippocampal blood flow at both time points (p = .0056; p = .034), although the effect at the second did not survive adjustment for the effect of global blood flow. These data indicate that oxytocin can modulate hippocampal function in CHR-P individuals and therefore merits further investigation as a candidate novel treatment for this group.


Asunto(s)
Hipocampo/irrigación sanguínea , Hipocampo/efectos de los fármacos , Hipocampo/fisiopatología , Oxitocina/administración & dosificación , Trastornos Psicóticos/fisiopatología , Administración Intranasal , Adolescente , Adulto , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Masculino , Trastornos Psicóticos/sangre , Factores de Riesgo , Adulto Joven
5.
Early Interv Psychiatry ; 11(5): 393-400, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-26332590

RESUMEN

AIM: This study aims to evaluate the outcomes and economic case for a UK innovative youth-specific mental health service for 16-25 year olds. METHODS: A pre-, during- and post-treatment comparative design for 20 young people at high risk of developing psychosis who received 2 years' treatment with the service, using outcomes that concurred with the service aims: changes in mental health, employment rates and service use. RESULTS: Forty-five percent of those at risk and with symptoms of serious mental illness commencing treatment were not receiving mental health services at baseline. Compared with service use prior to treatment at the youth-specific service, hospital admissions, Accident and Emergency, and criminal justice system use appear to decrease over the 2 years of treatment and the year after treatment, with potential cost differences of £473 000. Mental health improved or stayed the same, compared with baseline. Employment rates improved, although the sample size for this is very small. Potential cost differences associated with service users moving into employment over the 2 years are £148 000. The estimated cost over 2 years of providing the youth-specific mental health service to these young people was £106 000. CONCLUSIONS: Given the extensive long-term negative consequences and high costs of untreated mental illness in the 16-25 age group and the documented problems young people have in receiving appropriate services, this youth-specific, age-appropriate service model appears to be successful, with improved outcomes and cost differences in the short-term, and with encouraging implications for the longer term.


Asunto(s)
Servicios de Salud del Adolescente/organización & administración , Trastornos Mentales/terapia , Servicios de Salud Mental/organización & administración , Adolescente , Servicios de Salud del Adolescente/economía , Adulto , Factores de Edad , Femenino , Humanos , Masculino , Trastornos Mentales/economía , Servicios de Salud Mental/economía , Trastornos Psicóticos/economía , Trastornos Psicóticos/prevención & control , Trastornos Psicóticos/terapia , Resultado del Tratamiento , Reino Unido , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA